Inside the RadPartners-MEDNAX Fusion: What's To Come
Diagnostic Imaging spoke with Radiology Partners Chairman and CEO Rich Whitney, Associate CMO Nina Kottler, M.D., and MEDNAX Radiology Solutions CMO Ricardo Cury, M.D., about this newly finalized partnership, what it means for the companies, and how it could impact the industry.
On Dec. 16, Radiology Partners and MEDNAX Radiology Solutions announced the completion of their partnership – a deal that has been valued at $885 million.
This agreement fuses MEDNAX’s more than 800 radiologists with the 1,600 providers who currently work for Radiology Partners. More than 300 of MEDNAX’s providers currently work onsite in several states, and 500 more are teleradiologists.
Across the industry, this partnership is expected to open doors for larger clinical programs and significant levels of innovation. Diagnostic Imaging sat down with MEDNAX chief medical officer Ricardo Cury, M.D., as well as Radiology Partners chairman and chief executive officer Rich Whitney and associate chief medical officer Nina Kottler, M.D., to talk about why this merger is a good fit, what new capabilities it introduces, and what it could mean for radiology as a whole.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 3
August 2nd 2025In the third of a three-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, discuss strategies for maintaining the integrity of time-out procedures and communication with remote MRI scanning.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
August 2nd 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
